Some features may not work as expected in this browser. For the full NewsNow experience, please consider updating your browser or trying a different device. Some features may not work as expected.
Please consider updating your browser or device.

Home
Hot Topics
Australia
World
Sport
Business
Entertainment
Science
Technology
Lifestyle

Eli Lilly
Pharmaceuticals
Novo Nordisk
GSK
AstraZeneca
Topics

Advertisement

Advertisement

Eli Lilly

Share

Top Latest Popular

In the last 10 minutes

Forget Zepbound: Eli Lilly's Next Weight-Loss Drug Could Be Its Biggest Blockbuster Yet The Motley Fool 14:21

In the last 6 hours

Eli Lilly Just Announced Something Big. Here’s What It Means for Investors. The Motley Fool 10:17

Earlier Today

Lilly's Foundayo Pill Linked to 57% Lower Predicted Diabetes Risk in ATTAIN-1 Modeling, but No Cases Were Counted Medical Daily 00:06

Advertisement

Advertisement

Yesterday

Lilly's Ebglyss Cleared or Nearly Cleared Hand and Foot Eczema in 53% of Patients Versus 27% on Placebo Medical Daily 18:08 Sat, 03 Oct

Friday

Novo Nordisk Strikes Nearly $4 Billion in 2 Deals. Here's What That Means for Investors The Motley Fool 21:27 Fri, 02 Oct

Lilly's Jaypirca (pirtobrutinib), the first-and-only approved non-covalent Btk inhibitor, receives expanded indication from U.S. FDA for certain patients with previously untreated CLL/Sll PR Newswire (Press Release) 20:08 Fri, 02 Oct

Lilly's Eloralintide Plus Tirzepatide Produced 23.3% Weight Loss in Phase 2 Trial of Adults with Type 2 Diabetes Medical Daily 19:56 Fri, 02 Oct

Lilly's Foundayo Pill Matched Insulin on Heart Safety in Lancet Trial, but Its Lower Death Rate Needs Caution Medical Daily 19:56 Fri, 02 Oct

February 2027 Options Now Available For Eli Lilly (LLY) Nasdaq 15:59 Fri, 02 Oct

Katwijk approves permits for $3 billion Eli Lilly pharmaceutical plant NL Times 08:55 Fri, 02 Oct

Eli Lilly obesity drug data adds pressure on Novo Nordisk Proactive Investors (US) 07:38 Fri, 02 Oct

Thursday

Johnson & Johnson vs. Eli Lilly: Which Pharma Stock Can Make Your Portfolio Healthier in 2026? The Motley Fool 23:15 Thu, 01 Oct

Could Eli Lilly's Newest Weight Loss Strategy Pay Off for Decades? The Motley Fool 21:13 Thu, 01 Oct

‘India’s biotech ecosystem holds tremendous promise’: Eli Lilly CEO The Times of India 20:40 Thu, 01 Oct

Foghorn Therapeutics Pivots Pipeline after Ending Eli Lilly Deal Benzinga 17:26 Thu, 01 Oct

Novo Nordisk Licenses Experimental Once-Weekly Obesity Pill From China's Hengrui in Deal Worth Up to $2.6 Billion Medical Daily 16:28 Thu, 01 Oct

Advertisement

Lilly's triple GLP-1 combination raises the stakes for Novo Nordisk Proactive Investors (UK) 11:16 Thu, 01 Oct

New Lilly combo tops tirzepatide for weight loss in diabetes pharmaphorum 10:16 Thu, 01 Oct

New Lilly combo tops Zepbound for weight loss in diabetes pharmaphorum 10:06 Thu, 01 Oct

Lilly's Foundayo Shows Cardiovascular Safety, Sustained A1C And Weight Benefits In achieve-4 RTT News 05:09 Thu, 01 Oct

Eli Lilly Loses Full Fed. Circ. Bid To Nix Teva's $177M IP Win Law360 04:44 Thu, 01 Oct

Federal Circuit Denies En Banc Rehearing in Teva v. Eli Lilly, Preserving Precedent for Method-of-Treatment Patent Claims JD Supra 04:17 Thu, 01 Oct

Foundayo Pill Edged Higher-Dose Oral Semaglutide on Weight and A1C in Lilly's Indirect Type 2 Diabetes Analysis Medical Daily 03:15 Thu, 01 Oct

Novo Is Open to Acquisitions. Here Are 2 Companies That Would Be Great Candidates to Buy The Motley Fool 00:33 Thu, 01 Oct

Wednesday

Eli Lilly (LLY) Suffers a Larger Drop Than the General Market: Key Insights Zacks 23:46 Wed, 30 Sep

From Jab to Pills: Novo Nordisk, Eli Lilly set to take obesity drug battle to India The Economic Times 20:01 Wed, 30 Sep

'US-style medicine model' as big pharma dispensing of GLP-1s condemned ABC Online 19:59 Wed, 30 Sep

Lilly's EloraTZP Delivers Weight Loss Results In Phase 2b Trial RTT News 18:48 Wed, 30 Sep

2 Outstanding Dividend Stocks to Buy and Hold for a Decade The Motley Fool 18:37 Wed, 30 Sep

Lilly Drug Combo Spurs Record Weight Loss in Diabetes Study (1) Bloomberg Law 16:49 Wed, 30 Sep

Could This Company Challenge Eli Lilly and Novo Nordisk in the Weight Loss Market? The Motley Fool 15:34 Wed, 30 Sep

GLP-1 news round-up: what's happened in weight loss Manufacturing Chemist 15:29 Wed, 30 Sep

Tirzepatide or Semaglutide? Novo Nordisk Says Higher Semaglutide Dose Shows Cardiovascular Edge Over Eli Lilly's Tirzepatide (corrected) Benzinga 15:29 Wed, 30 Sep

Lilly's Ebglyss Shows Rapid Improvement In Hand And Foot Atopic Dermatitis In Phase 3b Study RTT News 15:24 Wed, 30 Sep

Eli Lilly’s Zepbound combined with amylin drug led to significant weight loss in mid-stage trial STAT 15:20 Wed, 30 Sep

Switching to Wegovy Pill Boosts Weight Loss NewsMax 12:44 Wed, 30 Sep

Lilly fleshes out triple G data in diabetes and obesity pharmaphorum 12:14 Wed, 30 Sep

Weight-loss drug helps diabetes patients lose 25% of their body weight The Independent 10:07 Wed, 30 Sep

Lilly reports comparative data from ACHIEVE-3 and PIONEER PLUS studies Hospital Management 08:36 Wed, 30 Sep

Lilly's Retatrutide Drives Significant Weight Loss And A1C Improvement In Phase 3 Diabetes Study RTT News 06:16 Wed, 30 Sep

Advertisement

Advertisement

About our Eli Lilly news

Latest news on on Eli Lilly and Company, an American pharmaceutical with headquarters in Indianapolis.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Business Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Takeda Takeda
- Teva Teva
- Zoetis Zoetis